Gorudkoa I.V.,Belarusian State University |
Kostevichb V.A.,Russian Academy of Medical Sciences |
Sokolovb A.V.,Russian Academy of Medical Sciences |
Bukod I.V.,Republican Science Practical Center Cardiology |
And 7 more authors.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | Year: 2011
Using a previously developed spectrophotometric method (Bioorg. Khim. 2009, vol. 35, pp. 629- 639) a significant increase of myeloperoxidase (MPO) activity (versus healthy control) was found in blood plasma of patients with type 2 diabetes mellitus (DM2) without cardiovascular complications, and also in patients with ischemic heart disease (IHD). The plasma MPO concentration measured by an enzyme-linked immunosorbent assay was significantly higher only in blood plasma of patients with DM2 and IHD. A signif- icant positive correlation between blood MPO activity and blood MPO content was observed only in blood plasma samples from healthy donors. Increased MPO activity did not correlate with MPO concentration in blood plasma of patients with DM2 and DM2 with IHD. Taken together, these results indicate that studies on the MPO role in the development of pathological processes should include simultaneous determination of both the amount of enzyme and its peroxidase activity in blood of patients. The proposed approach gives comprehensive information about the relationship between MPO activity and MPO concentration in patient's blood. Since the high concentration of MPO is a diagnostically important parameter for the predic- tion of development of endothelial dysfunction and cardiovascular diseases, the obtained results point to the contribution of MPO-dependent reactions in cardiovascular complications associated with diabetes mellitus. MPO activity may serve as an additional diagnostic criterion for determination of risk of IHD in DM patients. © Pleiades Publishing, Ltd., 2011. Source